The survival of glioblastoma has improved significantly! Electric field therapy combined with immunotherapy has great potential 07/06/2022 細胞瘤 IDH
Dovitinib, a new third-line treatment for advanced renal cell carcinoma, has submitted a new drug application. 07/06/2022 細胞瘤 RTKs
The survival of glioblastoma has improved significantly! Electric field therapy combined with immunotherapy has great potential 07/06/2022 細胞瘤 GBM
